Master_of_Fine_Charts

XERS- A little consolidation before take off

Long
NASDAQ:XERS   Xeris Biopharma Holdings, Inc.
After bottoming out in early December at the 200 sma it has made higher lows and the 9ema crossed the 20 ema. In addition both EMAs crossed the 50 sma showing us that the short and medium term trends are bullish. This will bounce around a bit in the $5.70-$5.09 range as it builds a new base before moving to new highs. It will see some resistance at $6.33

First target $7.16
Second target $7.68
Third target $8.68
Final Destination $11.60

I am long XERS and consider it a buy and add for 2021

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.